Jan 22(Reuters) - Shenzhen Neptunus Bioengineering Co Ltd :
* Says its wholly owned pharma tech unit received FDA approval for anti-tumor new drug clinical trail from U.S Food and Drug Administration
* The unit will be able to conduct clinical trial of anti-tumor new drug in the United States after receiving the FDA approval
Source text in Chinese: goo.gl/Ucdtfz
Further company coverage: (Beijing Headline News)
 